Virpax Pharmaceuticals, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Berwyn, PA
SEC filing record 1 source field available
Fiscal year end
31 December
Virpax Pharmaceuticals, Inc. has filed 278 SEC EDGAR filings since 05 Apr 2018

SEC filing history

Showing 176-200 of 278 matching filings.

Per page
25
Current page
8
DEFA14A File 001-40064

DEFINITIVE ADDITIONAL MATERIALS

Filing date
15 Jun 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-40064

DEFINITIVE PROXY STATEMENT

Filing date
15 Jun 2022
Reporting date
25 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
26 May 2022
Reporting date
24 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
20 May 2022
Reporting date
18 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
20 May 2022
Reporting date
18 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-40064

QUARTERLY REPORT

Filing date
16 May 2022
Reporting date
31 Mar 2022
Next action
Verify source filing
8-K File 001-40064

CURRENT REPORT

Filing date
16 May 2022
Reporting date
16 May 2022
Next action
Verify source filing
S-8 File 333-264767

REGISTRATION STATEMENT

Filing date
06 May 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
27 Apr 2022
Reporting date
25 Apr 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-40064

ANNUAL REPORT

Filing date
31 Mar 2022
Reporting date
31 Dec 2021
Next action
Verify source filing
8-K File 001-40064

CURRENT REPORT

Filing date
15 Mar 2022
Reporting date
15 Mar 2022
Next action
Verify source filing
4/A

4/A filing

Filing date
25 Feb 2022
Reporting date
31 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

4/A filing

Filing date
25 Feb 2022
Reporting date
31 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

4/A filing

Filing date
25 Feb 2022
Reporting date
31 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-92861

SC 13G

Filing date
14 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-92861

SCHEDULE 13G/A

Filing date
14 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-92861

VIRPAX PHARMACEUTICALS, INC.

Filing date
04 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Feb 2022
Reporting date
31 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Feb 2022
Reporting date
31 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Feb 2022
Reporting date
31 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
05 Jan 2022
Reporting date
01 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
05 Jan 2022
Reporting date
01 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
05 Jan 2022
Reporting date
01 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
05 Jan 2022
Reporting date
01 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .